REDX — Redx Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- £46.68m
- £46.27m
- £4.20m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.32 | -9.21 | -21.6 | -18 | -33.2 |
Depreciation | |||||
Non-Cash Items | -2.89 | 1.5 | 5.62 | 6.09 | 2.53 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.45 | 7.44 | -6.05 | 2.56 | -5.08 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.67 | 0.395 | -21.4 | -8.47 | -34.7 |
Capital Expenditures | -0.028 | -0.059 | -0.754 | -0.262 | -0.195 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.06 | 0.004 | 0 | 0.021 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | 0.032 | -0.055 | -0.754 | -0.241 | -0.195 |
Financing Cash Flow Items | 0.869 | -1.52 | -1.05 | -0.77 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.87 | 23.5 | 24.1 | 33 | -0.816 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.77 | 23.8 | 2.04 | 24.3 | -35.8 |